Skip to main content
Download PDF

Correction to: Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report

BMC Infectious Diseases volume 22, Article number: 371 (2022) Cite this article

The Original Article was published on 29 March 2022

Correction to: BMC Infectious Diseases (2022) 22:306 https://doi.org/10.1186/s12879-022-07288-4

Following publication of the original article [1], the authors identified that the given names and family names were erroneously transposed.

The incorrect authors’ names list is:

Petitgas Paul1,2*, Lesouhaitier Mathieu1, Boukthir Sarrah3, Cattoir Vincent3, Tattevin Pierre1 and Bénézit François1.

The correct authors’ names list is:

Paul Petitgas1,2,*, Mathieu Lesouhaitier1, Sarrah Boukthir3, Vincent Cattoir3, Pierre Tattevin1 and François Bénézit1.

The author group has been updated above and the original article [1] has been corrected.

Reference

  1. Petitgas P, Lesouhaitier M, Boukthir S, Cattoir V, Tattevin P, Bénézit F. BMC Infect Dis. 2022;22:306. https://doi.org/10.1186/s12879-022-07288-4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France

    Paul Petitgas, Mathieu Lesouhaitier, Pierre Tattevin & François Bénézit

  2. Infectious Diseases and Internal Medicine Unit, Saint-Pierre University Hospital, La Reunion, France

    Paul Petitgas

  3. Clinical Microbiology Laboratory Unit, Pontchaillou University Hospital, Rennes, France

    Sarrah Boukthir & Vincent Cattoir

Authors
  1. Paul Petitgas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathieu Lesouhaitier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sarrah Boukthir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincent Cattoir
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pierre Tattevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. François Bénézit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Petitgas.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Petitgas, P., Lesouhaitier, M., Boukthir, S. et al. Correction to: Cerebral nocardiosis in a patient treated with pembrolizumab: a first case report. BMC Infect Dis 22, 371 (2022). https://doi.org/10.1186/s12879-022-07343-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12879-022-07343-0

BMC Infectious Diseases

ISSN: 1471-2334

Contact us